The Medical Advisory Board provides high-level scientific and clinical expertise to IKCC. This ensures that the organisation provides evidence based leadership within the international kidney cancer community that includes all those involved in kidney cancer treatment care, research and advocacy, as well as patients and caregivers. In addition, the Medical Advisory Board represents and advocates for patient values and perspectives in major scientific committees and expert groups at both national and international levels.
Members of the Medical Advisory Board serve terms of 2 years with option to renew.
For more information, please contact Julia Black at email@example.com.